Request for Covid-19 Impact Assessment of this Report
The United States In-vitro Toxicity Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global In-vitro Toxicity Testing market, reaching US$ million by the year 2028. As for the Europe In-vitro Toxicity Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main In-vitro Toxicity Testing players cover Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., and CELTHER POLSKA Sp z o.o., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of In-vitro Toxicity Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Static Well Plate System
Multi-compartmental Perfused Systems
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
CELTHER POLSKA Sp z o.o.
Charles River Laboratories International Inc.
Eurofins GSC Lux Sarl
Evotec AG
General Electric Co.
Merck KGaA
Thermo Fisher Scientific Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global In-vitro Toxicity Testing Market Size 2017-2028
2.1.2 In-vitro Toxicity Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 In-vitro Toxicity Testing Segment by Type
2.2.1 Static Well Plate System
2.2.2 Multi-compartmental Perfused Systems
2.3 In-vitro Toxicity Testing Market Size by Type
2.3.1 In-vitro Toxicity Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global In-vitro Toxicity Testing Market Size Market Share by Type (2017-2022)
2.4 In-vitro Toxicity Testing Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Academic and Research Institutions
2.4.3 Others
2.5 In-vitro Toxicity Testing Market Size by Application
2.5.1 In-vitro Toxicity Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global In-vitro Toxicity Testing Market Size Market Share by Application (2017-2022)
3 In-vitro Toxicity Testing Market Size by Player
3.1 In-vitro Toxicity Testing Market Size Market Share by Players
3.1.1 Global In-vitro Toxicity Testing Revenue by Players (2020-2022)
3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2020-2022)
3.2 Global In-vitro Toxicity Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 In-vitro Toxicity Testing by Regions
4.1 In-vitro Toxicity Testing Market Size by Regions (2017-2022)
4.2 Americas In-vitro Toxicity Testing Market Size Growth (2017-2022)
4.3 APAC In-vitro Toxicity Testing Market Size Growth (2017-2022)
4.4 Europe In-vitro Toxicity Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa In-vitro Toxicity Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas In-vitro Toxicity Testing Market Size by Country (2017-2022)
5.2 Americas In-vitro Toxicity Testing Market Size by Type (2017-2022)
5.3 Americas In-vitro Toxicity Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In-vitro Toxicity Testing Market Size by Region (2017-2022)
6.2 APAC In-vitro Toxicity Testing Market Size by Type (2017-2022)
6.3 APAC In-vitro Toxicity Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe In-vitro Toxicity Testing by Country (2017-2022)
7.2 Europe In-vitro Toxicity Testing Market Size by Type (2017-2022)
7.3 Europe In-vitro Toxicity Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa In-vitro Toxicity Testing by Region (2017-2022)
8.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global In-vitro Toxicity Testing Market Forecast
10.1 Global In-vitro Toxicity Testing Forecast by Regions (2023-2028)
10.1.1 Global In-vitro Toxicity Testing Forecast by Regions (2023-2028)
10.1.2 Americas In-vitro Toxicity Testing Forecast
10.1.3 APAC In-vitro Toxicity Testing Forecast
10.1.4 Europe In-vitro Toxicity Testing Forecast
10.1.5 Middle East & Africa In-vitro Toxicity Testing Forecast
10.2 Americas In-vitro Toxicity Testing Forecast by Country (2023-2028)
10.2.1 United States In-vitro Toxicity Testing Market Forecast
10.2.2 Canada In-vitro Toxicity Testing Market Forecast
10.2.3 Mexico In-vitro Toxicity Testing Market Forecast
10.2.4 Brazil In-vitro Toxicity Testing Market Forecast
10.3 APAC In-vitro Toxicity Testing Forecast by Region (2023-2028)
10.3.1 China In-vitro Toxicity Testing Market Forecast
10.3.2 Japan In-vitro Toxicity Testing Market Forecast
10.3.3 Korea In-vitro Toxicity Testing Market Forecast
10.3.4 Southeast Asia In-vitro Toxicity Testing Market Forecast
10.3.5 India In-vitro Toxicity Testing Market Forecast
10.3.6 Australia In-vitro Toxicity Testing Market Forecast
10.4 Europe In-vitro Toxicity Testing Forecast by Country (2023-2028)
10.4.1 Germany In-vitro Toxicity Testing Market Forecast
10.4.2 France In-vitro Toxicity Testing Market Forecast
10.4.3 UK In-vitro Toxicity Testing Market Forecast
10.4.4 Italy In-vitro Toxicity Testing Market Forecast
10.4.5 Russia In-vitro Toxicity Testing Market Forecast
10.5 Middle East & Africa In-vitro Toxicity Testing Forecast by Region (2023-2028)
10.5.1 Egypt In-vitro Toxicity Testing Market Forecast
10.5.2 South Africa In-vitro Toxicity Testing Market Forecast
10.5.3 Israel In-vitro Toxicity Testing Market Forecast
10.5.4 Turkey In-vitro Toxicity Testing Market Forecast
10.5.5 GCC Countries In-vitro Toxicity Testing Market Forecast
10.6 Global In-vitro Toxicity Testing Forecast by Type (2023-2028)
10.7 Global In-vitro Toxicity Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories In-vitro Toxicity Testing Product Offered
11.1.3 Abbott Laboratories In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Agilent Technologies Inc.
11.2.1 Agilent Technologies Inc. Company Information
11.2.2 Agilent Technologies Inc. In-vitro Toxicity Testing Product Offered
11.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Agilent Technologies Inc. Main Business Overview
11.2.5 Agilent Technologies Inc. Latest Developments
11.3 Bio-Rad Laboratories Inc.
11.3.1 Bio-Rad Laboratories Inc. Company Information
11.3.2 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Offered
11.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bio-Rad Laboratories Inc. Main Business Overview
11.3.5 Bio-Rad Laboratories Inc. Latest Developments
11.4 CELTHER POLSKA Sp z o.o.
11.4.1 CELTHER POLSKA Sp z o.o. Company Information
11.4.2 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Offered
11.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 CELTHER POLSKA Sp z o.o. Main Business Overview
11.4.5 CELTHER POLSKA Sp z o.o. Latest Developments
11.5 Charles River Laboratories International Inc.
11.5.1 Charles River Laboratories International Inc. Company Information
11.5.2 Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Offered
11.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Charles River Laboratories International Inc. Main Business Overview
11.5.5 Charles River Laboratories International Inc. Latest Developments
11.6 Eurofins GSC Lux Sarl
11.6.1 Eurofins GSC Lux Sarl Company Information
11.6.2 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Offered
11.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Eurofins GSC Lux Sarl Main Business Overview
11.6.5 Eurofins GSC Lux Sarl Latest Developments
11.7 Evotec AG
11.7.1 Evotec AG Company Information
11.7.2 Evotec AG In-vitro Toxicity Testing Product Offered
11.7.3 Evotec AG In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Evotec AG Main Business Overview
11.7.5 Evotec AG Latest Developments
11.8 General Electric Co.
11.8.1 General Electric Co. Company Information
11.8.2 General Electric Co. In-vitro Toxicity Testing Product Offered
11.8.3 General Electric Co. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 General Electric Co. Main Business Overview
11.8.5 General Electric Co. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA In-vitro Toxicity Testing Product Offered
11.9.3 Merck KGaA In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Information
11.10.2 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Offered
11.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Thermo Fisher Scientific Inc. Main Business Overview
11.10.5 Thermo Fisher Scientific Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. In-vitro Toxicity Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Static Well Plate System
Table 3. Major Players of Multi-compartmental Perfused Systems
Table 4. In-vitro Toxicity Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global In-vitro Toxicity Testing Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global In-vitro Toxicity Testing Market Size Market Share by Type (2017-2022)
Table 7. In-vitro Toxicity Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global In-vitro Toxicity Testing Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global In-vitro Toxicity Testing Market Size Market Share by Application (2017-2022)
Table 10. Global In-vitro Toxicity Testing Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global In-vitro Toxicity Testing Revenue Market Share by Player (2020-2022)
Table 12. In-vitro Toxicity Testing Key Players Head office and Products Offered
Table 13. In-vitro Toxicity Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global In-vitro Toxicity Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global In-vitro Toxicity Testing Market Size Market Share by Regions (2017-2022)
Table 18. Americas In-vitro Toxicity Testing Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas In-vitro Toxicity Testing Market Size Market Share by Country (2017-2022)
Table 20. Americas In-vitro Toxicity Testing Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas In-vitro Toxicity Testing Market Size Market Share by Type (2017-2022)
Table 22. Americas In-vitro Toxicity Testing Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas In-vitro Toxicity Testing Market Size Market Share by Application (2017-2022)
Table 24. APAC In-vitro Toxicity Testing Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC In-vitro Toxicity Testing Market Size Market Share by Region (2017-2022)
Table 26. APAC In-vitro Toxicity Testing Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC In-vitro Toxicity Testing Market Size Market Share by Type (2017-2022)
Table 28. APAC In-vitro Toxicity Testing Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC In-vitro Toxicity Testing Market Size Market Share by Application (2017-2022)
Table 30. Europe In-vitro Toxicity Testing Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe In-vitro Toxicity Testing Market Size Market Share by Country (2017-2022)
Table 32. Europe In-vitro Toxicity Testing Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe In-vitro Toxicity Testing Market Size Market Share by Type (2017-2022)
Table 34. Europe In-vitro Toxicity Testing Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe In-vitro Toxicity Testing Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa In-vitro Toxicity Testing Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of In-vitro Toxicity Testing
Table 43. Key Market Challenges & Risks of In-vitro Toxicity Testing
Table 44. Key Industry Trends of In-vitro Toxicity Testing
Table 45. Global In-vitro Toxicity Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global In-vitro Toxicity Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global In-vitro Toxicity Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global In-vitro Toxicity Testing Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global In-vitro Toxicity Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global In-vitro Toxicity Testing Market Size Market Share Forecast by Application (2023-2028)
Table 51. Abbott Laboratories Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 52. Abbott Laboratories In-vitro Toxicity Testing Product Offered
Table 53. Abbott Laboratories In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. Agilent Technologies Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 57. Agilent Technologies Inc. In-vitro Toxicity Testing Product Offered
Table 58. Agilent Technologies Inc. Main Business
Table 59. Agilent Technologies Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Agilent Technologies Inc. Latest Developments
Table 61. Bio-Rad Laboratories Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 62. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Offered
Table 63. Bio-Rad Laboratories Inc. Main Business
Table 64. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bio-Rad Laboratories Inc. Latest Developments
Table 66. CELTHER POLSKA Sp z o.o. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 67. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Offered
Table 68. CELTHER POLSKA Sp z o.o. Main Business
Table 69. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. CELTHER POLSKA Sp z o.o. Latest Developments
Table 71. Charles River Laboratories International Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 72. Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Offered
Table 73. Charles River Laboratories International Inc. Main Business
Table 74. Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Charles River Laboratories International Inc. Latest Developments
Table 76. Eurofins GSC Lux Sarl Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 77. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Offered
Table 78. Eurofins GSC Lux Sarl Main Business
Table 79. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Eurofins GSC Lux Sarl Latest Developments
Table 81. Evotec AG Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 82. Evotec AG In-vitro Toxicity Testing Product Offered
Table 83. Evotec AG Main Business
Table 84. Evotec AG In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Evotec AG Latest Developments
Table 86. General Electric Co. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 87. General Electric Co. In-vitro Toxicity Testing Product Offered
Table 88. General Electric Co. Main Business
Table 89. General Electric Co. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. General Electric Co. Latest Developments
Table 91. Merck KGaA Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 92. Merck KGaA In-vitro Toxicity Testing Product Offered
Table 93. Merck KGaA Main Business
Table 94. Merck KGaA In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Merck KGaA Latest Developments
Table 96. Thermo Fisher Scientific Inc. Details, Company Type, In-vitro Toxicity Testing Area Served and Its Competitors
Table 97. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Offered
Table 98. Thermo Fisher Scientific Inc. Main Business
Table 99. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Thermo Fisher Scientific Inc. Latest Developments
List of Figures
Figure 1. In-vitro Toxicity Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global In-vitro Toxicity Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global In-vitro Toxicity Testing Market Size Market Share by Type in 2021
Figure 7. In-vitro Toxicity Testing in Pharmaceutical and Biotechnology Companies
Figure 8. Global In-vitro Toxicity Testing Market: Pharmaceutical and Biotechnology Companies (2017-2022) & ($ Millions)
Figure 9. In-vitro Toxicity Testing in Academic and Research Institutions
Figure 10. Global In-vitro Toxicity Testing Market: Academic and Research Institutions (2017-2022) & ($ Millions)
Figure 11. In-vitro Toxicity Testing in Others
Figure 12. Global In-vitro Toxicity Testing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global In-vitro Toxicity Testing Market Size Market Share by Application in 2021
Figure 14. Global In-vitro Toxicity Testing Revenue Market Share by Player in 2021
Figure 15. Global In-vitro Toxicity Testing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas In-vitro Toxicity Testing Market Size 2017-2022 ($ Millions)
Figure 17. APAC In-vitro Toxicity Testing Market Size 2017-2022 ($ Millions)
Figure 18. Europe In-vitro Toxicity Testing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa In-vitro Toxicity Testing Market Size 2017-2022 ($ Millions)
Figure 20. Americas In-vitro Toxicity Testing Value Market Share by Country in 2021
Figure 21. Americas In-vitro Toxicity Testing Consumption Market Share by Type in 2021
Figure 22. Americas In-vitro Toxicity Testing Market Size Market Share by Application in 2021
Figure 23. United States In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC In-vitro Toxicity Testing Market Size Market Share by Region in 2021
Figure 28. APAC In-vitro Toxicity Testing Market Size Market Share by Application in 2021
Figure 29. China In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe In-vitro Toxicity Testing Market Size Market Share by Country in 2021
Figure 36. Europe In-vitro Toxicity Testing Market Size Market Share by Type in 2021
Figure 37. Europe In-vitro Toxicity Testing Market Size Market Share by Application in 2021
Figure 38. Germany In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa In-vitro Toxicity Testing Market Size Market Share by Application in 2021
Figure 46. Egypt In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country In-vitro Toxicity Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 52. APAC In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 53. Europe In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 55. United States In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 56. Canada In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 59. China In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 60. Japan In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 61. Korea In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 63. India In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 64. Australia In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 65. Germany In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 66. France In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 67. UK In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 68. Italy In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 69. Russia In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 70. Spain In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 73. Israel In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries In-vitro Toxicity Testing Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...